These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 16571278)
1. Clinical study of Jiawei Huangqi Guizhi Wuwu Decoction in preventing and treating peripheral neuro-sensory toxicity caused by oxaliplatin. Li Y; Cui HJ; Huang JC; Wu XQ Chin J Integr Med; 2006 Mar; 12(1):19-23. PubMed ID: 16571278 [TBL] [Abstract][Full Text] [Related]
2. Study on efficacy and safety of Huangqi Guizhi Wuwu decoction treatment for oxaliplatin induced peripheral neurotoxicity: A protocol for a randomized, controlled, double-blind, multicenter trial. Wei XM; Chen XF; Shu P; Jiang ZW; Wu XY; Zou X; Chen K; Shen B; Hu WW; Lu W; Shen WX; Li L; Wang JY; Zhao FJ; Yin QF; Cheng HB; Gu YH Medicine (Baltimore); 2020 May; 99(22):e19923. PubMed ID: 32481364 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Huangqi Guizhi Wuwu Decoction for Oxaliplatin-Induced Peripheral Neurotoxicity: A Systematic Review and Meta-Analysis. Yu J; Chen S; Wei G; Gu J; Huo J; Ding R; Li L Altern Ther Health Med; 2024 Jan; 30(1):446-453. PubMed ID: 37820675 [TBL] [Abstract][Full Text] [Related]
4. Huangqi Guizhi Wuwu Decoction can prevent and treat oxaliplatin-induced neuropathic pain by TNFα/IL-1β/IL-6/MAPK/NF-kB pathway. Li M; Li Z; Ma X; Jin S; Cao Y; Wang X; Zhao J; Wang J; Wang X; Xu J Aging (Albany NY); 2022 Jun; 14(12):5013-5022. PubMed ID: 35759577 [TBL] [Abstract][Full Text] [Related]
5. Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy. Durand JP; Alexandre J; Guillevin L; Goldwasser F Anticancer Drugs; 2005 Jun; 16(5):587-91. PubMed ID: 15846125 [TBL] [Abstract][Full Text] [Related]
6. Huangqi Guizhi Wuwu decoction in peripheral neurotoxicity treatment using network pharmacology and molecular docking. Chen T; Shi Y; Shi W Medicine (Baltimore); 2022 Oct; 101(42):e31281. PubMed ID: 36281162 [TBL] [Abstract][Full Text] [Related]
7. Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial. Balayssac D; Ferrier J; Pereira B; Gillet B; Pétorin C; Vein J; Libert F; Eschalier A; Pezet D BMJ Open; 2015 Apr; 5(4):e007479. PubMed ID: 25833669 [TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of Huangqi Guizhi Wuwu decoction for rheumatoid arthritis: A protocol for systematic review and meta-analysis. Wang L; Fan Y; Xin P; Zhao Y; Deng H; Jia B Medicine (Baltimore); 2020 Sep; 99(36):e22011. PubMed ID: 32899051 [TBL] [Abstract][Full Text] [Related]
10. [Basic evidence for efficacy of Goshajinkigan on oxaliplatin-induced neuropathy]. Ushio S; Kawashiri T; Egashira N Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):126-30. PubMed ID: 24614635 [No Abstract] [Full Text] [Related]
11. An overview of chemotherapy-induced peripheral sensory neuropathy, focusing on oxaliplatin. Gent P; Massey K Int J Palliat Nurs; 2001 Jul; 7(7):354-9. PubMed ID: 11951404 [TBL] [Abstract][Full Text] [Related]
12. Laser acupuncture attenuates oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: a pilot prospective cohort study. Hsieh YL; Chou LW; Hong SF; Chang FC; Tseng SW; Huang CC; Yang CH; Yang CC; Chiu WF Acupunct Med; 2016 Oct; 34(5):398-405. PubMed ID: 27613370 [TBL] [Abstract][Full Text] [Related]
13. Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer. Argyriou AA; Cavaletti G; Briani C; Velasco R; Bruna J; Campagnolo M; Alberti P; Bergamo F; Cortinovis D; Cazzaniga M; Santos C; Papadimitriou K; Kalofonos HP Cancer; 2013 Jan; 119(2):438-44. PubMed ID: 22786764 [TBL] [Abstract][Full Text] [Related]
14. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570 [TBL] [Abstract][Full Text] [Related]
15. [Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study]. Eckel F; Schmelz R; Adelsberger H; Erdmann J; Quasthoff S; Lersch C Dtsch Med Wochenschr; 2002 Jan; 127(3):78-82. PubMed ID: 11797144 [TBL] [Abstract][Full Text] [Related]
16. [Promising effects of pregabalin in the treatment of oxaliplatin-induced sensory neuropathy in patients with colorectal carcinoma]. Nagahara H; Noda E; Maeda K; Inoue T; Hirakawa T; Hasegawa T; Shibutani M; Hirakawa K Gan To Kagaku Ryoho; 2013 Sep; 40(9):1181-3. PubMed ID: 24047775 [TBL] [Abstract][Full Text] [Related]
17. Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx Glimelius B; Manojlovic N; Pfeiffer P; Mosidze B; Kurteva G; Karlberg M; Mahalingam D; Buhl Jensen P; Kowalski J; Bengtson M; Nittve M; Näsström J Acta Oncol; 2018 Mar; 57(3):393-402. PubMed ID: 29140155 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of calcium and magnesium infusions in the chemoprevention of oxaliplatin-induced sensory neuropathy in gastrointestinal cancers. Xu XT; Dai ZH; Xu Q; Qiao YQ; Gu Y; Nie F; Zhu MM; Tong JL; Ran ZH J Dig Dis; 2013 Jun; 14(6):288-98. PubMed ID: 23432969 [TBL] [Abstract][Full Text] [Related]
20. Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study. Oki E; Emi Y; Kojima H; Higashijima J; Kato T; Miyake Y; Kon M; Ogata Y; Takahashi K; Ishida H; Saeki H; Sakaguchi Y; Yamanaka T; Kono T; Tomita N; Baba H; Shirabe K; Kakeji Y; Maehara Y Int J Clin Oncol; 2015 Aug; 20(4):767-75. PubMed ID: 25627820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]